Related Experiment Videos

Molecular and genetic characterization of human cell lines resistant to L-asparaginase and albizziin

I L Andrulis1, R Argonza, A E Cairney

  • 1Mount Sinai Hospital Research Institute, Toronto, Ontario, Canada.

Insights

Drug resistance in cancer cells was studied using L-asparaginase and albizziin. Resistant cell lines showed increased asparagine synthetase, with gene amplification in albizziin-resistant cells but not L-asparaginase-resistant cells.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • L-asparaginase and albizziin are drugs used in cancer therapy.
  • Resistance to these drugs can limit treatment efficacy.
  • Understanding resistance mechanisms is crucial for improving cancer treatments.

Purpose of the Study:

  • To investigate the mechanisms of resistance to L-asparaginase and albizziin in human cancer cell lines.
  • To characterize the changes in asparagine synthetase in drug-resistant cells.

Main Methods:

  • Multistep drug selection was used to generate resistant cell lines from HT1080 fibrosarcoma and MIA PaCa-2 pancreatic carcinoma.
  • Asparagine synthetase activity and protein levels were measured.
  • Gene amplification was assessed in resistant cell lines.

Main Results:

  • Resistant cell lines exhibited cross-resistance to both L-asparaginase and albizziin.
  • Elevated asparagine synthetase activity and protein levels (up to 17-fold) were observed in resistant cells.
  • Albizziin-resistant cells showed gene amplification of asparagine synthetase, while L-asparaginase-resistant cells showed increased expression without amplification.

Conclusions:

  • Increased asparagine synthetase is a key mechanism of resistance to L-asparaginase and albizziin.
  • Gene amplification is responsible for enzyme overproduction in albizziin resistance.
  • Increased gene expression without amplification underlies L-asparaginase resistance.

Related Concept Videos